Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Fosaprepitant
Medication labelFosaprepitant for injection, in combination with other antiemetic agents, is indicated in adults and pediatric patients 6 months of age and…
Why this: Advisory · dailymed-prescription
Fosaprepitant for injection, in combination with other antiemetic agents, is indicated in adults and pediatric patients 6 months of age and older for the prevention of: acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy (HEC) including high-dose cisplatin. delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy (MEC). Limitations of Use Fosaprepitant has not been studied for the treatment of established nausea and vomiting.
- generic_name
- fosaprepitant
- product_names
- FOSAPREPITANT
- ndc
- 63323-972, 63323-972-10
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en